 | | | | |  | | TRENDS IN PHARMACOLOGICAL SCIENCES | | | | | | |
| | | |
Editorial Board | |
Editor: | | | L. Balakrishnan |
| |
Assistant Editor: | | | P. Chapman |
| |
Editorial Coordinator | | | P. Lambert |
| |
Advisory Editorial Board: | | | S.G. Amara | University of Pittsburgh, Pittsburgh, PA, USA
| | | H. Betz | Max Planck Institute fur Hirnforschung, Frankfurt, Germany
| | | N.J.M Birdsall | National Institute of Medical Research, London, UK
| | | N.G. Bowery | University of Birmingham, UK
| | | J.N. Crawley | National Institute of Mental Health, Bethesda, MD, USA
| | | A.C. Cuello | McGill University, Montreal, Canada
| | | A. Dray | Astra Research Centre, Montreal, Quebec, Canada
| | | J.R. Fozard | Novartis Pharma, Basel, Switzerland
| | | B.B. Fredholm | Karolinska Institute, Stockholm, Sweden
| | | T. P. Kenakin | Glaxo Wellcome Research and Development, Research Triangle Park, NC, USA
| | | R. W. Kerwin | Institute of Psychiatry, London, U.K.
| | | B. K. Kobilka | Stanford University Medical Center, Stanford, CA, UK
| | | M. Lazdunski | Universite de Nice, Valbonne, France
| | | G-Q. Liu | China Pharmaceutical University, Nanjing, China
| | | C.A. Maggi | Menarini Ricerche SPA, Florence, Italy
| | | J. Meldolesi | University of Milan, Milan, Italy
| | | M. Mishina | University of Tokyo, Tokyo, Japan
| | | W.H. Moolenaar | Netherlands Cancer Institute, Amsterdam, The Netherlands
| | | C.P. Page | King's College, London, UK
| | | R. Ruffolo Jr. | Wyeth-Ayerst Research, King of Prussia, PA, USA
| | | T.K. Sawyer | Ariad Pharmaceuticals, Cambridge, MA, USA
| | | R.J. Summers | University of Melbourne, Melbourne, Australia
| | | T. Tanaka | University of Tsukuba,Tsu, Japan
| | | D. Wallach | Weizmann Institute of Science, Rehovot, Israel
| | | Z.G. Wang | Institute of Basic Medical Sciences, Beijing, PRC
| | | S.P. Watson | University of Birmingham, Birmingham, UK.
| |
| | | | |
| | |
|
